In light of its recent acquisition activity, Pfizer's (NYSE: PFE) latest asset purchase might seem small, but it's nevertheless significant. The company has agreed to pay up to nearly $1.6 billion to purchase ...
- Market Realist•yesterday
AstraZeneca (AZN) has four drugs that recently received approvals from regulatory authorities. Four other drugs recently received regulatory designations.
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||31.55 x 200|
|Ask||34.28 x 600|
|Day's Range||32.78 - 33.44|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||37.77|
|Avg Vol (3m)||6,152,448|
|Dividend & Yield||0.90 (2.69%)|